Volume 97 Number 4_Suppl
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Following the 2010 earthquake, Haiti was at heightened risk for vaccine-preventable diseases (VPDs) outbreaks due to the exacerbation of long-standing gaps in the vaccination program and subsequent risk of VPD importation from other countries. Therefore, partners supported the Haitian Ministry of Health and Population to improve vaccination services and VPD surveillance. During 2010–2016, three polio, measles, and rubella vaccination campaigns were implemented, achieving a coverage > 90% among children and maintaining Haiti free of those VPDs. Furthermore, Haiti is on course to eliminate maternal and neonatal tetanus, with 70% of communes achieving tetanus vaccine two-dose coverage > 80% among women of childbearing age. In addition, the vaccine cold chain storage capacity increased by 91% at the central level and 285% at the department level, enabling the introduction of three new vaccines (pentavalent, rotavirus, and pneumococcal conjugate vaccines) that could prevent an estimated 5,227 deaths annually. Haiti moved from the fourth worst performing country in the Americas in 2012 to the sixth best performing country in 2015 for adequate investigation of suspected measles/rubella cases. Sentinel surveillance sites for rotavirus diarrhea and meningococcal meningitis were established to estimate baseline rates of those diseases prior to vaccine introduction and to evaluate the impact of vaccination in the future. In conclusion, Haiti significantly improved vaccination services and VPD surveillance. However, high dependence on external funding and competing vaccination program priorities are potential threats to sustaining the improvements achieved thus far. Political commitment and favorable economic and legal environments are needed to maintain these gains.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

Loading full text...

Full text loading...



  1. WHO, 2008. Estimates of Disease Burden and Cost-Effectiveness. Available at: http://www.who.int/immunization/monitoring_surveillance/burden/estimates/en/. Accessed July 7, 2016.
  2. Pan American Health Organization (PAHO), 2006. Poliomyelitis Eradication Field Guide. 3rd edition. Available at: http://www.paho.org/hq/index.php?option=com_content&view=article&id=787%3A2009-polio-field-guide&catid=4049%3Apolio-publications&Itemid=1617&lang=en. Accessed July 7, 2016.
  3. Pan American Health Organization (PAHO), 2011. Plan of Action for the Documentation and Verification of Measles, Rubella, and Congenital Rubella Syndrome Elimination in the Region of the Americas. Washington, DC: PAHO.
  4. World Health Organization, 2016. Progress Towards Global MNT Elimination. Available at: http://www.who.int/immunization/diseases/MNTE_initiative/en/index4.html. Accessed July 7, 2016.
  5. WHO, 2016. WHO Vaccine-Preventable Diseases: Monitoring System. 2015 Global Summary. Available at: http://apps.who.int/immunization_monitoring/globalsummary/coverages?c=HTI. Accessed July 7, 2016.
  6. Rainey JJ, Danovaro-Holliday MC, Magloire R, Kananda G, Lee CE, Chamouillet H, Lacapere F, Mung K, Luman ET, , 2011. Haiti 2007–2008 national measles-rubella vaccination campaign: implications for rubella elimination. J Infect Dis 204 (Suppl 2): S616S621.[Crossref]
  7. Venczel L, Dobbins J, Andre J, Laender F, Izurieta H, Delorme P, Voltaire HC, , 2003. Measles eradication in the Americas: experience in Haiti. J Infect Dis 187 (Suppl 1): S127S132.[Crossref]
  8. De Quadros CA, Izurieta H, Carrasco P, Brana M, Tambini G, , 2003. Progress towards measles eradication in the region of the Americas. J Infect Dis 187 (Suppl 1): S102S110.[Crossref]
  9. Pan American Health Organization (PAHO), 2007. Resolution CSP27.R2. Elimination of Rubella and Congenital Rubella Syndrome in the Americas: Progress report. 27th Pan American Sanitary Conference. Washington, DC. Available at: http://www.paho.org/english/gov/csp/csp27-07-e.pdf. Accessed August 10, 2016.
  10. Pan-American Health Organization, 2011. Haiti Fact Sheet: Vaccination and Immunization, PAHO/WHO Technical Cooperation 2010–2011. Available at: http://www.paho.org/disasters/index.php?option=com_docman&task=doc_download&gid=2077&Itemid=. Accessed August 18, 2016.
  11. Rainey JJ, Sugerman D, Brennan M, Cadet JR, Ernsley J, Lacapere F, Danovaro-Holliday MC, Mubalama JC, Nandy R, , 2013. Rapid monitoring in vaccination campaigns during emergencies: the post-earthquake campaign in Haiti. Bull World Health Organ 91 : 957962.[Crossref]
  12. Pan American Health Organization (PAHO), 2012. Immunization Newsletter. August 2012. Available at: http://new.paho.org/hq/index.php?option=com_content&view=article&id=3130&Itemid=3504&lang=en. Accessed August 10, 2016.
  13. Tohme RA, ., 2014. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination. Trop Med Int Health 19 : 11051115.[Crossref]
  14. Fitter DL, Anselme R, Paluku G, Rey G, Flannery B, Tohme RA, Marston BJ, Griswold M, Boncy J, Vertefeuille JF, , 2013. Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012. Vaccine 32 : 6973.[Crossref]
  15. PAHO, 2015. Fact sheet: Elimination of Rubella and Congenital Rubella Syndrome in the Americas. Available at: http://www.paho.org/hq/index.php?option=com_content&view=category&layout=blog&id=831&Itemid=761&lang=en. Accessed July 7, 2016.
  16. PAHO, 2016. Fact Sheet: Measles Elimination in the Americas. Available at: http://www.paho.org/hq/index.php?option=com_content&view=article&id=12526%3Ameasles-elimination-in-the-americas&catid=6648%3Afact-sheets&Itemid=40721&lang=en. Accessed October 11, 2016.
  17. UNICEF, UNFPA, WHO, 2012. Achieving and Sustaining Maternal and Neonatal Tetanus Elimination: Strategic Plan 2012–2015. Available at: http://apps.who.int/immunization_monitoring/MNTEStrategicPlan_E.pdf. Accessed July 7, 2016.
  18. Cayemittes M, Busangu MF, Bizimana JD, Barrère B, Sévère B, Cayemittes V, Charles E, , 2013. Enquête Mortalité, Morbidité et Utilisation des Services, Haïti, 2012. Calverton, Maryland, USA: MSPP, IHE et ICF International. Available at: http://mspp.gouv.ht/site/downloads/EMMUS%20V%20document%20final.pdf. Accessed July 7, 2016.
  19. Kew O, ., 2002 Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296: 356359.[Crossref]
  20. WHO, 2013. Polio Eradication and Endgame Strategic Plan 2013–2018. Available at: http://www.polioeradication.org/Resourcelibrary/Strategyandwork.aspx. Accessed July 7, 2016.
  21. Lowther SA, ., 2013. World Health Organization regional assessments of the risks of poliovirus outbreaks. Risk Anal 4 : 664679.[Crossref]
  22. WHO/UNICEF, 2014. Immunization Supply Chain and Logistics: A Neglected But Essential System for National Immunization Programmes: Call to Action. Available at: http://www.who.int/immunization/call-to-action_ipac-iscl.pdf. Accessed July 7, 2016.
  23. WHO and UNICEF, 2016. Achieving Immunization Targets with the Comprehensive Effective Vaccine Management (EVM) Framework. Available at: http://www.who.int/immunization/programmes_systems/supply_chain/EVM-JS_final.pdf?ua=1. Accessed July 7, 2016.
  24. Pan American Health Organization, 2010. Vaccination supplies stock management (VSSM). PAHO Immunization Newsletter 32: 7. Available at: http://www.paho.org/immunization/toolkit/resources/paho-publication/job-aids/information-systems/Vaccination-Supplies-Stock-Management-VSSM.pdf?ua=1. Accessed July 7, 2016.
  25. Vinekar K, et al., 2015. Hospitalizations and deaths because of respiratory and diarrheal diseases among Haitian children under five years of age, 2011–2013. Pediatr Infect Dis J 34 : e238e243.[Crossref]
  26. World Health Organization, 2000. Estimated Hib and Peumococcal Deaths for Children Under 5 Years of Age 2000. Available at: http://www.who.int/immunization/monitoring_surveillance/burden/estimates/Pneumo_hib_2000/en/index1.html. Accessed July 7, 2016.
  27. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EI, Margolis HS, , 2005. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34 : 13291339.[Crossref]
  28. WHO, 2013. Estimated Rotavirus Deaths for Children Under 5 Years of Age. Available at: http://www.who.int/immunization/monitoring_surveillance/burden/estimates/rotavirus/en/. Accessed July 7, 2016.
  29. Tate JE, Burton AH, Boschi-Pinto C, Parashar UD;, World Health Organization–Coordinated Global Rotavirus Surveillance Network, 2016. Global, regional, and national estimates of rotavirus mortality in children < 5 years of age, 2000–2013. Clin Infect Dis 62 (Suppl 2): S96S105.[Crossref]
  30. WHO, 2013. Haemophilus influenza type b (Hib) vaccination position paper, July 2013. Wkly Epidemiol Record No. 39: 413–428.
  31. WHO, 2013. Rotavirus vaccines WHO position paper, January 2013. Wkly Epidemiol Record No. 5: 49–64.
  32. WHO, 2012. Pneumococcal vaccines WHO position paper—2012. Wkly Epidemiol Record No. 14: 129–144.
  33. WHO, 2009. Hepatitis B vaccines, WHO position paper. Wkly Epidemiol Record. No. 40: 405–420. Available at: http://www.who.int/wer/2009/wer8440.pdf. Accessed July 7, 2016.
  34. Tohme RA, ., 2016. Hepatitis B virus infection among pregnant women in Haiti: a cross-sectional serosurvey. J Clin Virol 76 : 6671.[Crossref]
  35. PAHO, Measles/Rubella Weekly Bulletins. Available at: http://www.paho.org/hq/index.php?option=com_topics&view=readall&cid=5956&Itemid=40899&lang=en. Accessed July 7, 2016.
  36. Steenland MW, ., 2013. Laboratory-confirmed cholera and rotavirus among patients with acute diarrhea in four hospitals in Haiti, 2012–2013. Am J Trop Med Hyg 89 : 641646.[Crossref]
  37. de Oliveira LH1, Danovaro-Holliday MC, Andrus JK, de Fillipis AM, Gentsch J, Matus CR, Widdowson MA; Rotavirus Surveillance Network, 2009. Sentinel hospital surveillance for rotavirus in Latin American and Caribbean countries. J Infect Dis 200 (Suppl 1): S131S139.[Crossref]
  38. Pan American Health Organization, 2014. Report from the Technical Advisory Group on Vaccine-Preventable Diseases (TAG). XXII meeting. Washington, DC: Pan American Health Organization.
  39. Vinje J, ., 2004. Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in Hispaniola. J Infect Dis 189 : 11681175.[Crossref]
  40. Pan American Health Organization, 2009. Diphtheria outbreak in Haiti, 2009. Immunization Newsletter 31 : 13.
  41. PAHO, 2016. Diphtheria in the Americas-Summary of the Situation. Available at: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=37504&lang=en. Accessed July 5, 2017.
  42. Adjagba A, Senouci K, Biellik R, Batmunkh N, Faye PC, Durupt A, Gessner BD, da Silva A, , 2015. Supporting countries in establishing and strengthening NITAGs: lessons learned from 5 years of the SIVAC initiative. Vaccine 33 : 588595.[Crossref]
  43. Jauregui B, Janusz CB, Clark AD, Sinha A, Garcia AG, Resch S, Toscano CM, Sanderson C, Andrus JK, , 2015. ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions. Vaccine 33 (Suppl 1): A21A27.[Crossref]
  44. World Health Organization, 2013. Global Vaccine Action Plan 2011–2020. Available at: http://www.who.int/immunization/global_vaccine_action_plan/en/. Accessed July 7, 2016.

Data & Media loading...

  • Received : 12 Oct 2016
  • Accepted : 19 Nov 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error